| Description |
1 online resource (26 pages) : color illustrations, color photographs |
| Contents |
Executive summary. -- Summary of recommendations. -- Introduction. -- Setting objectives for a U.S. national biotech strategy. -- Breaking down the bioeconomy. -- Drivers of the bio revolution. -- Measuring success in U.S. biotechnology development. -- Mitigating risks to the emerging bioeconomy. -- Recommendations to regenerate the U.S. bioeconomy. -- Conclusion. -- Appendix: structured interview questions |
| Summary |
The United States needs some form of industrial policy to promote its bioeconomy--one that is enshrined in democratic values and focused on improving access to four key drivers of bioeconomic growth: equipment, personnel, information, and capital. This report attempts to measure the health and outlook of the U.S. synthetic biology industry and broader bioeconomy by examining U.S. access to each of these four resources. It concludes that the United States still possesses an advantage in each of these fields--but that, absent a proactive strategy to ensure resource access, and without a significant infusion of capital, the U.S. bioeconomy risks languishing behind competitors such as China in the decades ahead |
| Notes |
"July 2022"--Cover |
| Bibliography |
Includes bibliographical references (pages 21-26) |
| Notes |
Online resource; title from PDF cover page (CNAS, viewed August 4, 2022) |
| Subject |
Biotechnology industries -- Government policy -- United States
|
|
Biotechnology industries -- United States -- Evaluation
|
|
Biotechnology -- Research -- Government policy -- United States
|
|
Biotechnology industries -- Government policy.
|
|
Biotechnology -- Research -- Government policy.
|
|
United States.
|
| Form |
Electronic book
|
| Author |
Center for a New American Security, publisher.
|
|
